33 related articles for article (PubMed ID: 34846626)
1. Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.
O'Reilly DE; Dooley L; Watson GA; Clarke R; Nolan A; Nolan C; Berkeley E; Farrell M; McDevitt T; Rogers M; Clabby C; Gallagher DJ
Ir J Med Sci; 2023 Aug; 192(4):1607-1611. PubMed ID: 36260241
[TBL] [Abstract][Full Text] [Related]
2. Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think?
McCuaig JM; Ferguson SE; Vicus D; Ott K; Stockley TL; Kim RH; Metcalfe KA
Hered Cancer Clin Pract; 2022 Apr; 20(1):15. PubMed ID: 35418215
[TBL] [Abstract][Full Text] [Related]
3. Characterization of patients with a diagnosis of breast cancer and melanoma: genetic susceptibility or increased surveillance?
Jia KY; Menes TS; Bernstein-Molho R; Nissan A; Zippel D
Eur J Cancer Prev; 2023 Sep; 32(5):418-422. PubMed ID: 36912151
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes.
Morgan J; MacInnes E; Erskine S; Walters SJ; Cook J; Collins K; Wyld L
Ann R Coll Surg Engl; 2024 Jan; 106(1):78-91. PubMed ID: 37458196
[TBL] [Abstract][Full Text] [Related]
5. Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience.
Rummel SK; Lovejoy LA; Turner CE; Shriver CD; Ellsworth RE
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963545
[TBL] [Abstract][Full Text] [Related]
6. Choices for cancer prevention for women with a BRCA1 mutation? a personal view.
Narod SA
Hered Cancer Clin Pract; 2023 Nov; 21(1):26. PubMed ID: 38031144
[TBL] [Abstract][Full Text] [Related]
7. Mainstreaming genetic testing of cancer predisposition genes.
Rahman N
Clin Med (Lond); 2014 Aug; 14(4):436-9. PubMed ID: 25099850
[No Abstract] [Full Text] [Related]
8. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.
Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L
Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing in women with breast cancer: implications for treatment.
Paterson R; Phillips KA
Expert Rev Anticancer Ther; 2017 Nov; 17(11):991-1002. PubMed ID: 28853307
[TBL] [Abstract][Full Text] [Related]
10. Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning.
Metcalfe KA; Eisen A; Wright F; Poll A; Candib A; McCready D; Cil T; Armel S; Silberman Y; Brennenstuhl S; Narod SA
Breast Cancer Res Treat; 2022 Feb; 191(3):631-641. PubMed ID: 34846626
[TBL] [Abstract][Full Text] [Related]
11. Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.
Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Lerner-Ellis J; McCuaig J; Graham T; Sun P; Akbari M; Narod SA
Ann Surg Oncol; 2021 Apr; 28(4):2219-2226. PubMed ID: 32989658
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
[TBL] [Abstract][Full Text] [Related]
13. Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.
Graves KD; Vegella P; Poggi EA; Peshkin BN; Tong A; Isaacs C; Finch C; Kelly S; Taylor KL; Luta G; Schwartz MD
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):445-55. PubMed ID: 22328347
[TBL] [Abstract][Full Text] [Related]
14. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
15. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
